Chromatin remodeling and human disease

Current Opinion in Genetics and Development

Volumn 13, Issue 3, 2003, Pages 246-252

  Huang, Cheng ^a   Sloan, Emily A ^a   Boerkoel, Cornelius F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DNA;

ACETYLATION; CANCER INHIBITION; CELL CYCLE; CHROMATIN; DNA METHYLATION; DNA MODIFICATION; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; GENETIC IDENTIFICATION; HUMAN; MODEL; NEOPLASM; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0038012544     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(03)00054-6     Document Type: Review

References (50)

1. Kadam S., Emerson B.M. Mechanisms of chromatin assembly and transcription. Curr. Opin. Cell Biol. 14:2002;262-268.
2. Ogryzko V.V. Mammalian histone acetyltransferases and their complexes. Cell Mol. Life Sci. 58:2001;683-692.
3. Havas K., Whitehouse I., Owen-Hughes T. ATP-dependent chromatin remodeling activities. Cell Mol. Life Sci. 58:2001;673-682.
4. Berube N.G., Smeenk C.A., Picketts D.J. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum. Mol. Genet. 9:2000;539-547.
5. Gibbons R.J., McDowell T.L., Raman S., O'Rourke D.M., Garrick D., Ayyub H., Higgs D.R. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet. 24:2000;368-371.
6. van Hoffen A., Natarajan A.T., Mayne L.V., van Zeeland A.A., Mullenders L.H., Venema J. Deficient repair of the transcribed strand of active genes in Cockayne's syndrome cells. Nucleic Acids Res. 21:1993;5890-5895.
7. Osterod M., Larsen E., Le Page F., Hengstler J.G., Van Der Horst G.T., Boiteux S., Klungland A., Epe B. A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene. 21:2002;8232-8239.
8. Boerkoel C.F., Takashima H., John J., Yan J., Stankiewicz P., Rosenbarker L., Andre J.L., Bogdanovic R., Burguet A., Cockfield S.et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat. Genet. 30:2002;215-220.
9. Betz B.L., Strobeck M.W., Reisman D.N., Knudsen E.S., Weissman B.E. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 21:2002;5193-5203 This paper provided evidence that loss of hSNF5 contributes to tumorigenesis. By introducing hSNF5 into multiple deficient cell lines, re-expression of hSNF5 inhibited colony formation and induced cell-cycle arrest concurrent with activation of the retinoblastoma protein.
10. Neely K.E., Workman J.L. The complexity of chromatin remodeling and its links to cancer. Biochim. Biophys. Acta. 1603:2002;19-29.
11. Klochendler-Yeivin A., Muchardt C., Yaniv M. SWI/SNF chromatin remodeling and cancer. Curr. Opin. Genet. Dev. 12:2002;73-79.
12. Reisman D.N., Strobeck M.W., Betz B.L., Sciariotta J., Funkhouser W. Jr., Murchardt C., Yaniv M., Sherman L.S., Knudsen E.S., Weissman B.E. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene. 21:2002;1196-1207 The authors observed concomitant down-regulation of BRG1 and BRM in human tumor cell lines and showed that re-expression of BRM can restore retinoblastoma protein mediated cell-cycle arrest. The findings suggest some functional redundancy of BRG1 and BRM.
13. Strobeck M.W., Reisman D.N., Gunawardena R.W., Betz B.L., Angus S.P., Knudsen K.E., Kowalik T.F., Weissman B.E., Knudsen E.S. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J. Biol. Chem. 277:2002;4782-4789.
14. Tse C., Sera T., Wolffe A.P., Hansen J.C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell Biol. 18:1998;4629-4638.
15. Timmermann S., Lehrmann H., Polesskaya A., Harel-Bellan A. Histone acetylation and disease. Cell Mol. Life Sci. 58:2001;728-736.
16. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
17. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
18. Murata T., Kurokawa R., Krones A., Tatsumi K., Ishii M., Taki T., Masuno M., Ohashi H., Yanagisawa M., Rosenfeld M.G.et al. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum. Mol. Genet. 10:2001;1071-1076 This paper correlates the human phenotype with that observed in mutant mice. When a mutation identical to a human missense mutation was introduced into the mouse Cbp gene, it abolished the HAT activity and the ability of the Cbp protein to transactivate CREB.
19. Gayther S.A., Batley S.J., Linger L., Bannister A., Thorpe K., Chin S.F., Daigo Y., Russell P., Wilson A., Sowter H.M.et al. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24:2000;300-303.
20. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J.M., Iwama T., Miyaki M. p300 gene alterations in colorectal and gastric carcinomas. Oncogene. 12:1996;1565-1569.
21. Kung A.L., Rebel V.I., Bronson R.T., Ch'ng L.E., Sieff C.A., Livingston D.M., Yao T.P. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14:2000;272-277.
22. Sugita K., Taki T., Hayashi Y., Shimaoka H., Kumazaki H., Inoue H., Konno Y., Taniwaki M., Kurosawa H., Eguchi M. MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosomes Cancer. 27:2000;264-269.
23. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell. 89:1997;341-347.
24. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 88:1997;471-481.
25. Wan M., Zhao K., Lee S.S., Francke U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum. Mol. Genet. 10:2001;1085-1092.
26. Johnstone R.W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1:2002;287-299.
27. Simon J.A., Tamkun J.W. Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes. Curr. Opin. Genet. Dev. 12:2002;210-218 This paper provides a review of the modulation of chromatin structure mediated by the Polycomb and trithorax group complexes and the consequent regulation of gene expression.
28. Felsenfeld G., Groudine M. Controlling the double helix. Nature. 421:2003;448-453 This paper provides an overview of chromatin structure and dynamics and the relationship between chromatin structure and epigenetics.
29. Guan Z., Giustetto M., Lomvardas S., Kim J.H., Miniaci M.C., Schwartz J.H., Thanos D., Kandel E.R. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell. 111:2002;483-493 This study begins to make the connection between dynamic complex neural processes and chromatin structure. It shows that serotonin and FMRFamide mediate their effects on synaptic plasticity through alterations in histone acetylation.
30. Bochar D.A., Wang L., Beniya H., Kinev A., Xue Y., Lane W.S., Wang W., Kashanchi F., Shiekhattar R. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 102:2000;257-265.
31. Zhang H.S., Gavin M., Dahiya A., Postigo A.A., Ma D., Luo R.X., Harbour J.W., Dean D.C. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell. 101:2000;79-89.
32. Olave I., Wang W., Xue Y., Kuo A., Crabtree G.R. Identification of a polymorphic, neuron-specific chromatin remodeling complex. Genes Dev. 16:2002;2509-2517.
33. Xue Y., Canman J.C., Lee C.S., Nie Z., Yang D., Moreno G.T., Young M.K., Salmon E.D., Wang W. The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc. Natl. Acad. Sci. U.S.A. 97:2000;13015-13020.
34. Tate P., Lee M., Tweedie S., Skarnes W.C., Bickmore W.A. Capturing novel mouse genes encoding chromosomal and other nuclear proteins. J. Cell Sci. 111:1998;2575-2585.
35. Poot R.A., Dellaire G., Hulsmann B.B., Grimaldi M.A., Corona D.F., Becker P.B., Bickmore W.A., Varga-Weisz P.D. HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins. EMBO J. 19:2000;3377-3387.
36. LeRoy G., Orphanides G., Lane W.S., Reinberg D. Requirement of RSF and FACT for transcription of chromatin templates in vitro. Science. 282:1998;1900-1904.
37. Santoro R., Li J., Grummt I. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat. Genet. 32:2002;393-396 The authors provided evidence that NoRC represses rDNA transcription. NoRC mediates rDNA silencing by recruiting DNA methyltransferase and HDAC activity to the rDNA promoter. These results link chromatin remodeling to DNA methylation and specific histone modifications.
38. Zhou Y., Santoro R., Grummt I. The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription. EMBO J. 21:2002;4632-4640.
39. Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1999;1924-1935.
40. Xu W., Edmondson D.G., Roth S.Y. Mammalian GCN5 and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates. Mol. Cell Biol. 18:1998;5659-5669.
41. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643.
42. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell. 102:2000;463-473.
43. Jacobson S.W., Chiodo L.M., Jacobson J.L. Breastfeeding effects on intelligence quotient in 4- and 11-year-old children. Pediatrics. 103:1999;e71.
44. Iizuka M., Stillman B. Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein. J. Biol. Chem. 274:1999;23027-23034.
45. Thomas T., Voss A.K., Chowdhury K., Gruss P. Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development. Development. 127:2000;2537-2548.
46. Dunphy E.L., Johnson T., Auerbach S.S., Wang E.H. Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression. Mol. Cell Biol. 20:2000;1134-1139.
47. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., Kimura A., Nakamura Y., Inazawa J., Abe T.et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int. J. Cancer. 89:2000;217-223.
48. Kawasaki H., Schiltz L., Chiu R., Itakura K., Taira K., Nakatani Y., Yokoyama K.K. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature. 405:2000;195-200.
49. Hsieh Y.J., Kundu T.K., Wang Z., Kovelman R., Roeder R.G. The TFIIIC90 subunit of TFIIIC interacts with multiple components of the RNA polymerase III machinery and contains a histone-specific acetyltransferase activity. Mol. Cell Biol. 19:1999;7697-7704.
50. Grozinger C.M., Hassig C.A., Schreiber S.L. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4868-4873.